Future of heart medicine: Stem cells to grow cardiac muscle and smaller medical implants

heart

If heart transplantation – 50 years after Christiaan Barnard carried out the first operation – has become routine, what exactly will medicine be capable of in the future? Will we one day be able to build, or even grow, replacement hearts, or will surgeons be able to use genetically modified animal hearts in their place?

New techniques are badly needed because the number of donor organs – about 200 per year in the UK – is dwarfed by demand. About 2,000 people under the age of 65 a year will die of heart failure without a transplant. One option researchers hope to develop is to use stem cells to grow new cardiac muscle.

An alternative to growing new hearts is to refine devices that can keep a patient alive until they can have a transplant. In recent years, the left ventricular assist device (LVAD) – an artificial pump that helps the left side of the heart do its job – has shrunk from a large external piece of kit to a tiny battery-operated device that can be implanted into the chest.

The key to the future is not likely to be any single technology, but a combination of all of them. But if the past 50 years have taught us anything at all, it is that things that seem impossible today will become the medicine of tomorrow.

Read full, original post: What will medicine be able to do with hearts?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.